Charles River Laboratories | Pasivo Circulante



Current Liabilities Cambio Fecha
Agilent USD 1.87B 26M 2025-01
Align Technology USD 1.99B 47.08M 2025-03
Bio-Rad Laboratories USD 506.6M 38.8M 2025-03
Bruker USD 1.28B 37.5M 2024-12
Cardinal Health USD 36.66B 1.44B 2025-03
Charles River Laboratories USD 994.1M 18.12M 2024-12
Cigna USD 55.74B 2.23B 2025-03
CVS Health USD 88.96B 4.35B 2025-03
Danaher USD 6.64B 153M 2025-03
Dentsply International USD 1.59B 47M 2024-12
Elevance Health 40.36B 1.67B 2024-12
Galapagos EUR 437.04M 101.96M 2025-03
Hologic USD 989.7M 12.7M 2025-03
Humana 16.94B 1.79B 2024-12
Illumina USD 1.55B 572M 2024-12
Incyte USD 1.89B 244.96M 2025-03
IQVIA Holdings USD 7.18B 222M 2025-03
Laboratory Of America USD 2.06B 1.27B 2025-03
Lonza CHF 3.58B 970M 2024-12
McKesson USD 58.56B 209M 2024-12
Merck EUR 11.29B 831M 2024-12
Mettler Toledo International USD 1.15B 18.5M 2025-03
Novartis USD 28.69B 560M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
Quest Diagnostics USD 1.44B 728M 2025-03
Revvity USD 648.19M 4.91M 2025-03
Thermo Fisher Scientific USD 13.17B 158M 2025-03
United Therapeutics USD 721.5M 16.6M 2025-03
UnitedHealth 103.77B 2.2B 2024-12
Walgreens Boots Alliance USD 26.58B 868M 2025-02
Waters USD 960.97M 171.21M 2025-03
West Pharmaceutical Services USD 526.7M 23.7M 2025-03



Charles River Laboratories Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.